IPAR
Signal
Mixed11
Price
1
Move+2.20%Positive session
Volume
1
Volume1.2× avgNormal activity
Technical
1
RSIRSI 46Momentum negative
PRICE
Prev Close
89.73
Open
89.73
Day Range89.52 – 92.17
89.52
92.17
52W Range77.21 – 142.61
77.21
142.61
22% of range
VOLUME & SIZE
Avg Volume
259.7K
FUNDAMENTALS
P/E Ratio
17.5x
EPS (TTM)
Div Yield
0.02%
Beta
0.99
Market-like
Performance
1D
+2.20%
5D
+2.34%
1M
+1.14%
3M
-9.17%
6M
+0.49%
YTD
+8.10%
1Y
-16.92%
Best: YTD (+8.10%)Worst: 1Y (-16.92%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
64% gross margin
Valuation
FAIR
P/E 18x vs ~20x sector
Health
STRONG
CR 3.3 · FCF $6.21/sh
Bullish
Key MetricsTTM
Market Cap$2.94B
Revenue TTM$1.49B
Net Income TTM$201.10M
Free Cash Flow$198.98M
Gross Margin64.0%
Net Margin13.5%
Operating Margin18.0%
Return on Equity23.2%
Return on Assets13.0%
Debt / Equity0.08
Current Ratio3.26
EPS TTM$6.28
Alpha SignalsFull Analysis →
What Moves This Stock

Same-store sales growth and market share gains in key geographic markets (U.S., France, Germany, Middle East, China)

New license acquisitions or renewals of existing agreements, particularly with high-profile luxury brands

Travel retail recovery and duty-free channel performance, which drives disproportionate margin contribution

Foreign exchange movements, particularly EUR/USD given European operations dominance and dollar-denominated reporting

Macro Sensitivity
Economic Cycle

moderate-to-high - Prestige fragrances are discretionary luxury purchases with income elasticity. During economic downturns, consumers trade down to mass-market fragrances or delay purchases, impacting volumes and pricing. However, fragrances represent accessible luxury (lower price points than handbags or apparel), providing some resilience. Travel retail exposure creates additional cyclicality tied to international tourism and business travel patterns. The consumer defensive sector classification understates actual cyclical exposure given luxury positioning.

Interest Rates

Rising interest rates have modest direct impact on operations given low debt levels (0.26 D/E ratio) and minimal financing costs. Indirect effects include reduced consumer discretionary spending as borrowing costs increase and wealth effects from equity market valuations. Higher rates also strengthen the dollar, creating FX headwinds on European operations when translated to USD reporting. Valuation multiples compress as investors rotate from growth/consumer discretionary to defensive sectors.

Key Risks

License concentration and renewal risk: Revenue dependent on maintaining relationships with luxury brand licensors who could choose to bring fragrance operations in-house or switch to competitors. Loss of major licenses (Montblanc, Coach, Jimmy Choo) would materially impact revenue.

Retail channel disruption: Ongoing shift from department stores to e-commerce and direct-to-consumer models threatens traditional distribution. Department store closures and reduced foot traffic impact primary sales channels.

Changing consumer preferences toward niche/artisanal fragrances and away from celebrity/designer brands could erode market share in prestige segment.

Investor Profile

value-oriented investors seeking exposure to luxury goods sector with lower volatility than pure-play fashion houses. The 20.3% ROE, 5.7% FCF yield, and reasonable valuation (2.2x P/S, 10.8x EV/EBITDA) attract investors looking for profitable, cash-generative businesses trading below luxury peer multiples. Dividend potential (strong FCF conversion) appeals to income-focused investors. Recent 25% one-year decline has attracted opportunistic value buyers betting on travel retail recovery and normalization of department store traffic.

Watch on Earnings
U.S. dollar index (DXY) and EUR/USD exchange rate for translation impact on European segment earningsDepartment store traffic and same-store sales trends (Macy's, Nordstrom, Sephora comps as proxies)International tourist arrivals and travel retail sales data from major airport operatorsConsumer confidence indices in key markets (U.S., France, Germany, China) for discretionary spending outlook
Health Radar
5 strong1 watch
78/100
Liquidity
3.26Strong
Leverage
0.08Strong
Coverage
48.7xStrong
ROE
23.2%Strong
ROIC
17.4%Strong
Cash
$158MWatch
ANALYST COVERAGE16 analysts
BUY
+17.2%upside to target
L $103.00
Med $107.50consensus
H $112.00
Buy
956%
Hold
744%
9 Buy (56%)7 Hold (44%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 46 — Bearish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 3.26 — healthy liquidity
Upcoming Events
EEarnings Report · Before OpenMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentAug 6, 2026
In 92 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 6.0%

-4.8% vs SMA 50 · -10.4% vs SMA 200

Momentum

RSI45.8
Neutral territory
MACD-1.76
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$142.6+55.5%
EMA 200
$103.4+12.8%
EMA 50
$93.68+2.2%
Current
$91.70
52W Low
$77.21-15.8%
52-Week RangeNear 52-week low
$77.2122th %ile$142.6
Squeeze SetupVolume-based
Distribution Pressure

Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.

20-Day Money Flow
Acc days:2
Dist days:7
Edge:+5 dist
Volume Context
Avg Vol (50D)201K
Recent Vol (5D)
269K+34%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 4 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$1.3B
$1.3B$1.3B
$4.36
±1%
Moderate3
FY2024
$1.5B
$1.4B$1.5B
+9.2%$5.14+17.9%
±1%
Moderate4
FY2025
$1.5B
$1.5B$1.5B
+2.5%$5.16+0.4%
±0%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryIPAR
Last 8Q
+6.6%avg beat
Beat 6 of 8 quartersMissed 2
+9%
Q3'24
+5%
Q4'24
-6%
Q1'25
+17%
Q2'25
-10%
Q3'25
+11%
Q4'25
+13%
Q1'26
+14%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
BWS FinancialNeutral → Buy
Nov 21
DOWNGRADE
BWS FinancialBuy → Neutral
Nov 21
DOWNGRADE
JefferiesBuy
Jul 11
UPGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Madar JeanDir
$1.8M
Apr 2
SELL
Benacin PhilippeDir
$2.1M
Dec 11
SELL
Harrison GilbertDir
$54K
Jun 23
SELL
Santi PhilippeDir
$45K
Jun 11
SELL
Santi PhilippeDir
$139K
Jun 10
SELL
Santi PhilippeDir
$95K
Jun 11
SELL
Financials
Dividends3.49% yield
+3.8% avg annual growth
Annual Yield3.49%
Quarterly Div.$0.8000
Est. Annual / Share$3.20
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
DEPRINCE RACE & ZOLLO INC
333K
2
Tributary Capital Management, LLC
114K
3
PRINCIPAL FINANCIAL GROUP INC
106K
4
ENVESTNET ASSET MANAGEMENT INC
91K
5
CBOE Vest Financial, LLC
66K
6
Granite Investment Partners, LLC
49K
7
BURNEY CO/
44K
8
Nuveen, LLC
38K
News & Activity

IPAR News

20 articles · 4h ago

About

Founded in 1982, Inter Parfums, Inc. develops, manufactures and distributes prestige perfumes and cosmetics as the exclusive worldwide licensee for Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Dunhill, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Lily Aldridge, Kate Spade, Montblanc, Oscar de la Renta, Paul Smith, Repetto, S.T. Dupont and Van Cleef & Arpels. Inter Parfums is also the owner of Lanvin fragrances and the Rochas brand. Through its global distribution network, the Company’s products are sold in over 100 countries.

Industry
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Frederic Garcia-PelayoExecutive Vice President & Chief Operating Officer of Interparfums SA
Philippe BenacinCo-Founder, Vice Chairman & President
PeersConsumer Defensive(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
IPAR
$91.70+2.20%$2.9B14.6+249.1%1131.2%1500
$130.79+0.35%$1.0T47.6+472.5%307.0%1517
$1016.42+0.36%$450.9B52.8+816.7%294.3%1503
$78.48+0.37%$337.8B24.6+187.0%2734.0%1506
$144.90+1.05%$337.5B21.0+29.2%1895.3%1488
$169.46+0.16%$264.1B23.9+731.3%2791.8%1502
$155.04+0.29%$211.9B24.2+225.5%877.3%1497
Sector avg+0.68%29.8+387.3%1433.0%1502